Takeda Pharmaceutical Co. TAK

18.86 0.27 1.45% as of 25 Sep
Market cap
$59.2B
P/E
28.4×
Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
P/E ratio
0.00 65.94 9.76 116.50 16.02 21.80 21.40 42.87 49.75 27.45
P/S ratio
2.38 2.40 1.92 1.56 1.90 1.41 1.72 1.45 1.59 1.94
P/FCF ratio
3.98 3.99 4.57 11.06 7.39 5.36 20.07 25.38 6.87 5.33
P/Operating CF
22.26 22.30 17.05 27.71 15.64 13.10 21.51 21.76 8.47 9.22
P/B ratio
2.13 2.02 1.76 1.09 1.17 0.89 1.09 0.85 0.95 1.17
Price to Tangible BV
7.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
2.51 2.79 2.29 2.91 3.03 2.38 2.67 2.48 2.55 2.83
EV/EBITDA
0.00 5.92 7.49 14.00 3.17 8.14 9.30 11.22 11.90 10.59
EV/Operating CF
3.50 3.85 4.36 14.30 9.60 7.57 10.99 14.76 7.15 5.34
EV/FCF
4.21 4.63 5.44 20.62 11.82 9.06 31.18 43.28 11.06 7.77
Quick Ratio
0.60 1.09 0.59 0.66 1.02 0.75 0.50 0.51 0.45 0.53
Current Ratio
0.92 1.46 1.22 1.13 1.53 1.21 0.97 1.11 1.01 1.09
Net Debt/EBITDA
2.03 1.44 10.53 6.49 1.19 3.32 3.32 4.64 3.72 5.84
Debt/Assets
26.28% 24.00% 41.46% 39.73% 35.90% 32.97% 31.40% 32.06% 31.69% 31.47%
Debt/Equity
0.59 0.49 1.11 1.08 0.90 0.76 0.69 0.67 0.65 0.66
Asset Turnover
0.45 0.41 0.23 0.25 0.25 0.27 0.27 0.28 0.31 0.30
Operating CF/Net income
2.27 2.02 3.01 15.14 2.69 4.88 3.08 4.97 9.80 (6.83)
Capex/Depreciation
(0.49) (0.69) (0.31) (0.35) (0.34) (0.32) (0.95) (0.65) (0.50) (0.57)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
6.14% 9.27% 3.04% 0.90% 7.67% 4.13% 4.81% 2.05% 1.48% (2.12%)
ROA
2.96% 4.34% 1.21% 0.34% 2.95% 1.72% 2.13% 0.96% 0.72% (1.02%)
ROIC
3.58% 5.75% 1.26% 0.68% 17.72% 3.15% 3.01% 1.15% 1.94% 0.03%
Return on Tangible Assets
27.06% 21.28% 5.88% 2.63% 15.71% 11.33% 19.72% 6.45% 5.44% (6.41%)
Average Days of Receivables
93.73 88.40 130.38 87.05 92.76 74.08 61.78 59.72 57.78 70.99
Research and Development Expense of Revenue
18.03% 18.38% 17.56% 14.96% 14.25% 14.74% 15.73% 17.12% 15.94% 15.00%
Selling, General and Administrative Expense of Revenue
35.74% 35.48% 34.22% 29.31% 27.38% 24.83% 24.76% 24.72% 24.11% 24.06%
Intangible Assets out of Total Assets
0.48 0.50 0.65 0.64 0.62 0.62 0.65 0.64 0.63 0.59
Share Based Compensation of Revenue
0.00% 1.05% 0.96% 0.88% 1.18% 1.22% 1.51% 1.66% 1.59% 1.62%
Graham Net Nets
(0.12) (0.25) (0.29) (1.09) (0.83) (0.97) (0.75) (0.85) (0.70) (0.52)
Graham Number
0.00 0.00 0.00 6.40 19.99 15.46 16.20 10.73 15.16 15.01
Earnings Yield
(1.61%) 1.52% 10.25% 0.86% 6.24% 4.59% 4.67% 2.33% 2.01% 3.64%
Free Cash Flow Yield
25.10% 25.05% 21.88% 9.04% 13.53% 18.66% 4.98% 3.94% 14.56% 18.77%
Revenue per Share
10.31 10.20 9.82 9.72 9.62 10.16 9.60 9.40 9.58 9.44
Operating CF per Share
1.56 2.18 1.54 1.98 3.04 3.20 2.33 1.58 2.21 2.18
Capex per Share
(0.65) (0.72) (0.39) (0.61) (0.57) (0.52) (1.51) (1.04) (0.79) (0.86)
Free Cash Flow per Share
0.91 1.46 1.15 1.37 2.47 2.67 0.82 0.54 1.42 1.33
Cash per Share
2.24 2.16 3.39 1.93 3.02 2.49 1.32 1.04 0.85 1.33
Shareholders Equity per Share
11.60 11.63 24.17 13.97 15.58 16.18 15.15 16.04 14.50 15.57
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
11.60 11.63 24.17 13.97 15.58 16.18 15.15 16.04 14.50 15.57
Free Cash Flow
1,416.75 2,273.01 2,205.74 4,274.50 7,716.61 8,356.06 2,548.78 1,685.12 4,472.39 4,179.29
Working Capital
(980.49) 3,071.69 4,857.54 2,700.51 8,833.34 3,986.41 (621.48) 1,693.79 96.83 1,705.63
Capital Expenditures
(1,013.92) (1,127.67) (750.57) (1,887.21) (1,786.14) (1,639.58) (4,682.18) (3,257.66) (2,505.01) (2,694.15)
Net Current Asset Value
(10,659.25) (9,092.22) (50,922.69) (51,742.43) (47,208.90) (43,617.60) (38,517.90) (36,405.84) (31,621.74) (32,936.34)
EV/EBIT
0.00 5.92 7.49 95.40 3.88 18.45 21.90 49.37 57.30 28.91
Capex to Sales
0.06 0.07 0.04 0.06 0.06 0.05 0.16 0.11 0.08 0.09
Net Profit Margin
6.64% 10.56% 5.20% 1.34% 11.76% 6.45% 7.87% 3.38% 2.36% (3.38%)
Price to Operating Income
0.00 5.10 6.29 51.18 2.43 10.92 14.09 28.96 35.59 19.81
Other line items
Depreciation/Fixed assets
0.42 0.34 0.21 0.42 0.38 0.37 0.39 0.37 0.39 0.34
Cash ROIC
(7.75%) (4.71%) (8.49%) (6.84%) (4.10%) (4.22%) (6.32%) (10.11%) (7.68%) (8.33%)
Accounts Receivable Turnover
4.18 3.99 3.56 4.34 4.05 4.51 5.19 5.97 6.30 5.63
Accounts Payable Turnover
2.72 2.03 2.32 3.41 (3.03) 2.52 1.96 2.29 3.02 3.25
Inventory Turnover
2.47 2.22 1.10 1.26 (1.33) 1.34 1.24 1.26 1.27 1.20
Average Days of Payables
157.18 176.83 181.14 106.78 (126.22) 170.26 190.48 140.08 109.84 114.11
Days of Inventory on Hand
147.82 156.73 545.96 254.42 (276.74) 281.35 289.42 309.53 281.18 324.36
Average Receivables
3,855.09 3,997.78 5,300.60 6,981.67 7,430.39 7,043.23 5,745.74 4,929.02 4,800.09 5,285.29
Average Payables
1,911.92 2,200.06 2,554.44 2,939.83 3,082.59 3,913.56 4,699.68 4,291.11 3,458.23 3,190.72
Average Inventory
2,106.41 2,010.52 5,398.60 7,934.50 7,037.40 7,339.83 7,446.48 7,823.94 8,191.30 8,626.10
Average Assets
36,124.34 38,733.47 80,904.54 121,402.50 119,664.85 119,330.00 110,285.90 103,769.05 99,144.89 98,207.49
Average Common Equity
17,409.18 18,141.03 32,314.49 44,982.58 46,079.17 49,624.41 48,803.96 48,607.60 47,984.05 47,409.88

Fold the line items

Columns are period end dates